Please login to the form below
research
This page shows the latest research news and features for those working in and with pharma, biotech and healthcare.
Stop that!
Mental prison. I remember the day of my release. I was sitting in my garden, looking at some research data and having one of those moments that every scientist will recognise. ... My research data was supposed to identify both that model and the
Latest news
-
Keytruda doubles five-year survival rate in NSCLC
an encouraging new precedent in the first-line metastatic non-small cell lung cancer setting,” said Roy Barnes, senior vice president and head of global clinical development at Merck Research Laboratories.
-
UK COVID-19 vaccine ‘challenge trials’ could intentionally infect participants with virus
UK human ‘challenge trial’ programme would be a world first
-
FDA hands BMS and bluebird bio a priority review for ide-cel
Updated review accepted after refuse-to-file letter was issued in May
-
Janssen’s EGFR-targeting treatment regimen shows early benefit in lung cancer
Positive interim results presented at 2020 ESMO virtual congress
-
AZ/Merck's Lynparza improves survival in certain prostate cancers
New data released at ESMO 2020 virtual congress shows drug cuts the risk of death
More from news
Approximately 125 fully matching, plus 4,734 partially matching documents found.
Latest Intelligence
-
BiTE* platform and the evolution toward off-the-shelf immuno-oncology approaches
The therapeutic potential that immuno-oncology hopes to deliver is always expanding, fueled by the vision that drives ambitious research.
-
Surviving cancer: a new era for patients
In 2015 the EUROCARE-5 study – the biggest collaborative research project on cancer survival in Europe – showed that between 2000 and 2007, 5-year relative survival rates for most cancers increased ... Research has shown that reframing a patient’s
-
Could formulary intelligence be your brand differentiator?
Proprietary research, and the COVID-19 experience, shows how formulary intelligence can drive competitive advantage at launch. ... Nonetheless, irrespective of the offering, research suggests that the industry’s Y1 expectations (and projections) are
-
How COVID-19 is accelerating the threat of antimicrobial resistance
This included the Global Antibiotic Research and Development Partnership (GARDP) and the British Society for Antimicrobial Chemotherapy (BSAC). ... HCPs again shared webinars that focused particularly on the long-term impact of COVID-19 on AMR research
-
Exploiting the value of data in pharma
Competing businesses need to share information, research and, importantly, data in a way that might have been inconceivable just a few months ago. ... This, in turn, can assist in calibrating countermeasures and accelerating research and development.
More from intelligence
Approximately 29 fully matching, plus 702 partially matching documents found.
Latest appointments
-
Evoke KYNE promotes Dante DelVecchio to senior VP
Most recently, Grodin worked as the director of strategic communications for the Population Council, a global non-profit research organisation addressing critical health and development issues.
-
Ex-J&J exec Denice Torres joins bluebird bio’s board
Torres brings over 25 years of executive management experience to the role
-
Azafaros expands executive team with three senior hires
Also joining the senior team is Ruben Giorgino (pictured above), who has been appointed head of clinical research and development. ... He joins from Helsinn Group, where he held the position of global head of clinical research and development.
-
McCann Health France strengthens team with two new hires
Initially, she worked on the research and development of new drugs in cardiovascular and metabolic diseases before specialising in oncology and onco-haematology. ... Prior to McCann Health France, she served as scientific director at various
-
NICE looks internally for new chief executive
Originally training in medicine, Leng went on to work on clinical trials and epidemiological research as well as a consultant in public health medicine.
More from appointments
Approximately 32 fully matching, plus 745 partially matching documents found.
Latest from PMHub
-
Crisis? No problem!
research (e.g.
-
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise. The Tufts Center for the Study of Drug Development (CSDD) collected data on 87 clinical trials from four top-20 pharma companies and one
-
Improve clinical trials through patient journey mapping
Find the clinical study website – the information is more understandable, but often doesn’t have contact details for more information, only the research site and postcode.
-
Havas Health & You Launches Behind the Mask, a Global Research Initiative to Document Health Experiences During the COVID-19 Pandemic and Beyond
Havas Health &You (HH&Y) have launched the details of a long-term global research project, Behind the Mask, a longitudinal, multi-armed study which focuses on documenting the ongoing evolution ... The ongoing research can be found at
-
MarketsResearch.biz
MarketsResearch.Biz is a single destination for all the industry, company and country reports. We have a leading market intelligence team which accredits and provides the reports of some of the top publishers in the field of the technology industry.
More from PMHub
Approximately 206 fully matching, plus 1,011 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- New study identifies drugs that are safe to use in COVID-19 treatment
- BioNTech bolsters COVID-19 vaccine capacity with Novartis deal
- Pfizer’s ALK inhibitor Lorbrena hits the mark in head-to-head lung cancer trial
- BMS eyes approval for second Opdivo combo in kidney cancer
- FDA hands BMS and bluebird bio a priority review for ide-cel
- 20 for 2020 – Five pharma companies to watch
- Using Artificial Intelligence to Transform Pharma
- Session 4: Systems Innovation Insight and Thinking
- Transforming Unstructured Healthcare Information into Real-World Evidence & Life Saving Insights
- UK COVID-19 vaccine ‘challenge trials’ could intentionally infect participants with virus
- Keytruda doubles five-year survival rate in NSCLC
- EMA fast-tracks review of bluebird bio’s LentiGlobin for sickle cell disease
PMHub
Iguazu
Iguazu Ltd is a digital healthcare agency, delivering tactical and innovative solutions. WHAT WE DO We are Closed Loop Marketing...
Latest intelligence
- Surviving cancer: a new era for patients
- Now more than ever, a shift in perspective is needed...
- Crisis? No problem!
- Issues planning & management for pharma spokespeople, by Andrew Smith...
- Are patient recruitment and retention rates rising or falling?
- First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....
Quick links
Infographics
